Invention Grant
- Patent Title: Compositions and methods of treatment using a BCAT1 inhibitor
-
Application No.: US15243428Application Date: 2016-08-22
-
Publication No.: US10941109B2Publication Date: 2021-03-09
- Inventor: Adonia E. Papathanassiu
- Applicant: Ergon Pharmaceuticals, LLC
- Applicant Address: US MD Silver Spring
- Assignee: Ergon Pharmaceuticals, LLC
- Current Assignee: Ergon Pharmaceuticals, LLC
- Current Assignee Address: US MD Silver Spring
- Agency: Wenderoth, Lind & Ponack, LLP
- Main IPC: C07C255/21
- IPC: C07C255/21 ; C07C59/84
Abstract:
The present invention is directed to compounds and methods that inhibit the cytosolic form of BCAT1.
Public/Granted literature
- US20160368862A1 COMPOSITIONS AND METHODS OF TREATMENT USING A BCAT1 INHIBITOR Public/Granted day:2016-12-22
Information query
